Fluorescein Angiography (International Symposium, Albi, 1969: Proceedings) || Fluorescein Angiography in Optic Atrophy
- 作者Amalric, P.
- 文件大小965.02KB
- 发表时间1972
- DOI10.1159/000392618
- 页码573-577
Activators of the farnesoid X receptor negatively regulate androgen glucuronidation in human prostate cancer LNCAP cellsKaeding, Jenny; Bouchaert, Emmanuel; Bélanger, Julie; Caron, Patrick; Chouinard, Sarah; Verreault, Mélanie; Larouche, Olivier; Pelletier, Georges; Staels, Bart; Bélanger, Alain; Barbier, Olivier · Biochemical Journal · 2008
Isolation and characterization of a simian UDP-glucuronosyltransferase UGT2B18 active on 3-hydroxyandrogensMartin Beaulieu; Eric Lévesque; Olivier Barbier; David Turgeon; Guy Bélanger; Dean W Hum; Alain Bélanger · 1998
Characterization of UDP-glucuronosyltransferases active on steroid hormonesDean W. Hum; Alain Bélanger; Éric Lévesque; Olivier Barbier; Martin Beaulieu; Caroline Albert; Michel Vallée; Chantal Guillemette; André Tchernof; David Turgeon; Stéphanie Dubois · 1999
Molecular cloning, expression and characterization of a monkey steroid UDP-glucuronosyltransferase, UGT2B19, that conjugates testosteroneGuy Bélanger; Olivier Barbier; Dean W. Hum; Alain Bélanger · 1999
Inactivation of androgens by UDP-glucuronosyltransferases in the human prostateOlivier Barbier; Alain Bélanger · 2008
Inactivation of androgens by UDP-glucuronosyltransferase enzymes in humansAlain Bélanger; Georges Pelletier; Fernand Labrie; Olivier Barbier; Sarah Chouinard · 2003
A pharmacogenomics study of the human estrogen glucuronosyltransferase UGT1A3Caillier, Bertrand; Lépine, Johanie; Tojcic, Jelena; Ménard, Vincent; Perusse, Louis; Bélanger, Alain; Barbier, Olivier; Guillemette, Chantal · Pharmacogenetics and Genomics · 2007
Inactivation by UDP-glucuronosyltransferase enzymes: The end of androgen signalingSarah Chouinard; Mei-Fei Yueh; Robert H. Tukey; Frank Giton; Jean Fiet; Georges Pelletier; Olivier Barbier; Alain Bélanger · 2008